Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
19 mars 2024 07h55 HE
|
Clearmind Medicine Inc.
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:...
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
18 mars 2024 07h29 HE
|
SciSparc Ltd
TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of...
Feit Electric Announces Second Patent Enforcement Action Against Infringing White LED Filaments
13 mars 2024 16h20 HE
|
Feit Electric
Feit Electric Company, Inc. today commenced a second white filament patent infringement action against Savant Technologies doing business as GE Lighting
Zerify Unveils Strategic Initiative to Leverage Its Patent Portfolio and Combat Infringement
07 mars 2024 07h58 HE
|
Zerify
Zerify is leveraging their strong patents after seeing some possilbne infringers and realizing the potential.
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
07 mars 2024 07h49 HE
|
SciSparc Ltd
The Company's most recent patent further solidifies its position, complementing existing grants in the U.S., Japan, Australia and other key jurisdictions TEL AVIV, Israel, March 07, 2024 ...
1 Day Online Training Course on Effective Defence of EPO (European Patent Office) Patent Applications
27 févr. 2024 12h14 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Effective Defence of EPO (European Patent Office) Patent Applications Training Course" has been added to ResearchAndMarkets.com's offering. Clarity...
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
27 févr. 2024 07h58 HE
|
Clearmind Medicine Inc.
New patent applications build upon Clearmind’s broad IP protection in the psychedelic space Vancouver, Canada, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE:...
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
27 févr. 2024 07h58 HE
|
SciSparc Ltd
TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
GeoVax Announces Multiple Patent Issuances and Allowances
13 févr. 2024 09h00 HE
|
GeoVax, Inc.
Intellectual Property Assets Strengthened for Cancer Immunotherapy Programand for Marburg Virus and HIV Vaccines ATLANTA, GA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc....
UnitedLex Source Code Analysis Uncovers Crucial Evidence Leading to a 5G Standard Patent Infringement Verdict Awarding $67.5 Million, Plus Ongoing Royalties
06 févr. 2024 11h10 HE
|
UnitedLex Corporation
UnitedLex completed source code analysis for Carter Arnett and produced critical evidence leading to a verdict of $67.5M plus for G+ Communications.